
Loading, please wait...

Loading, please wait...

Researchers recently investigated subcutaneous pacing excitability through a detailed preclinical study. Unlike traditional systems, extravascular devices provide therapy without direct myocardial contact. Consequently, understanding their electrical properties is vital for future innovation. The team conducted acute experiments in swine using a specialized coil-to-can configuration. Furthermore, they delivered asynchronous pulses at rates above the intrinsic heart rhythm. They confirmed successful capture using high-fidelity intra-aortic pressure monitoring.
The subjects consistently displayed a hyperbolic strength-duration profile. This pattern matches the classical expectations of Lapicque’s theory. Moreover, the study identified rheobase values ranging from 19.54 to 77.58 mA. Similarly, chronaxie varied between 0.70 and 2.94 ms. An inverse relationship exists between these two parameters in this setting. Therefore, factors like tissue impedance and electrode geometry likely dictate the stimulation profile. While biphasic waveforms showed lower thresholds than monophasic ones, the difference remained statistically insignificant.
These findings offer a clear roadmap for optimizing cardiac rhythm management devices. Specifically, the data support strategies to enhance battery life in subcutaneous systems. Because thresholds follow predictable pulse width dependencies, engineers can refine energy delivery safety margins. Furthermore, these results encourage the development of more efficient extravascular pacing solutions. Ultimately, such advancements will benefit patients who require therapy without intravascular lead placement.
The key parameters are rheobase and chronaxie. Rheobase represents the minimum current required for capture at infinite pulse duration. Chronaxie is the pulse duration required at twice the rheobase current.
Lapicque’s theory provides a mathematical model for the strength-duration relationship. It helps clinicians and engineers predict the electrical energy needed to stimulate the heart effectively across different pulse widths.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. While we strive for accuracy, please consult a qualified healthcare professional for any health concerns or diagnostic needs. Refer to the latest local and national guidelines for clinical practice.
References
Bennett P et al. Strength-Duration Characterisation of Subcutaneous Pacing: A Preclinical Study. Pacing Clin Electrophysiol. 2026 Apr 18. doi: 10.1111/pace.70256. PMID: 42001245.
Zanon F. Energy Saving in Permanent Cardiac Pacing: Pulse Waveform and Charge Balancing Deserve Consideration. MDPI. 2025.
Mond HG. The history of cardiac pacing: a celebration of 50 years. Pacing Clin Electrophysiol. 2008.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Preclinical study defines subcutaneous pacing excitability using Lapicque's model to guide the design of future extravascular cardiac rhythm devices....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today